Literature DB >> 32901967

Concomitant changes in ventricular depolarization and repolarization and long-term outcomes of biventricular pacing.

Christoffer Polcwiartek1,2,3, Daniel J Friedman4, Kasper Emerek2, Claus Graff5, Peter L Sørensen5, Joseph Kisslo1, Zak Loring1,6, Steen M Hansen2, Kristian Kragholm2, Bhupendar Tayal2, Svend E Jensen2,3, Peter Søgaard2,3, Christian Torp-Pedersen2,7, Brett D Atwater1.   

Abstract

BACKGROUND: Biventricular (BiV) pacing increases transmural repolarization heterogeneity due to epicardial to endocardial conduction from the left ventricular (LV) lead. However, limited evidence is available on concomitant changes in ventricular depolarization and repolarization and long-term outcomes of BiV pacing. Therefore, we investigated associations of BiV pacing-induced concomitant changes in ventricular depolarization and repolarization with mortality (i.e., LV assist device, heart transplantation, or all-cause mortality) and sustained ventricular arrhythmia endpoints.
METHODS: Consecutive BiV-defibrillator recipients with digital preimplantation and postimplantation electrocardiograms recorded between 2006 and 2015 at Duke University Medical Center were included. We calculated changes in QRS duration and corrected JT (JTc) interval and split them by median values. For simplicity, these variables were named QRSdecreased (≤ -12 ms), QRSincreased (> -12 ms), JTcdecreased (≤22 ms), and JTcincreased (> 22 ms) and subsequently used to construct four mutually exclusive groups.
RESULTS: We included 528 patients (median age, 68 years; male, 69%). No correlation between changes in QRS duration and JTc interval was observed (P = .295). Compared to QRSdecreased /JTcincreased , increased risk of the composite mortality endpoint was associated with QRSdecreased /JTcdecreased (hazard ratio [HR] = 1.62; 95% confidence interval [CI] = 1.09-2.43), QRSincreased /JTcdecreased (HR = 1.86; 95% CI = 1.27-2.71), and QRSincreased /JTcincreased (HR = 2.25; 95% CI = 1.52-3.35). No QRS/JTc group was associated with excess sustained ventricular arrhythmia risk (P = .400).
CONCLUSION: Among BiV-defibrillator recipients, QRSdecreased /JTcincreased was associated with the most favorable long-term survival free of LV assist device, heart transplantation, and sustained ventricular arrhythmias. Our findings suggest that improved electrical resynchronization may be achieved by assessing concomitant changes in ventricular depolarization and repolarization.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  biventricular pacing; cardiac resynchronization therapy; heart failure; implantable cardioverter-defibrillator; ventricular arrhythmias; ventricular repolarization

Year:  2020        PMID: 32901967      PMCID: PMC7669630          DOI: 10.1111/pace.14065

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  28 in total

1.  Pacing-induced increase in QT dispersion predicts sudden cardiac death following cardiac resynchronization therapy.

Authors:  Shajil Chalil; Zaheer R Yousef; Sarkaw A Muyhaldeen; Russell E A Smith; Paul Jordan; Christopher R Gibbs; Francisco Leyva
Journal:  J Am Coll Cardiol       Date:  2006-06-20       Impact factor: 24.094

2.  Cardiac Resynchronization Therapy With Wireless Left Ventricular Endocardial Pacing: The SELECT-LV Study.

Authors:  Vivek Y Reddy; Marc A Miller; Petr Neuzil; Peter Søgaard; Christian Butter; Martin Seifert; Peter Paul Delnoy; Lieselot van Erven; Martin Schalji; Lucas V A Boersma; Sam Riahi
Journal:  J Am Coll Cardiol       Date:  2017-05-02       Impact factor: 24.094

3.  Non-invasively quantified changes in left ventricular activation predict outcomes in patients undergoing cardiac resynchronization therapy.

Authors:  Daniel J Friedman; Kasper Emerek; Steen Møller Hansen; Christoffer Polcwiartek; Peter L Sørensen; Zak Loring; Joanne Sutter; Peter Søgaard; Joseph Kisslo; Claus Graff; Brett D Atwater
Journal:  J Cardiovasc Electrophysiol       Date:  2019-10-08

Review 4.  Avoiding non-responders to cardiac resynchronization therapy: a practical guide.

Authors:  Claude Daubert; Nathalie Behar; Raphaël P Martins; Philippe Mabo; Christophe Leclercq
Journal:  Eur Heart J       Date:  2017-05-14       Impact factor: 29.983

5.  Meta-Analysis of the Usefulness of Change in QRS Width to Predict Response to Cardiac Resynchronization Therapy.

Authors:  Panagiotis Korantzopoulos; Zhiwei Zhang; Guangping Li; Nikolaos Fragakis; Tong Liu
Journal:  Am J Cardiol       Date:  2016-08-13       Impact factor: 2.778

6.  Usefulness of electrocardiographic QT interval to predict left ventricular diastolic dysfunction.

Authors:  Jane E Wilcox; Jonathan Rosenberg; Ajay Vallakati; Mihai Gheorghiade; Sanjiv J Shah
Journal:  Am J Cardiol       Date:  2011-09-10       Impact factor: 2.778

7.  Prognostic significance of corrected QT and corrected JT interval for incident coronary heart disease in a general population sample stratified by presence or absence of wide QRS complex: the ARIC Study with 13 years of follow-up.

Authors:  Richard S Crow; Peter J Hannan; Aaron R Folsom
Journal:  Circulation       Date:  2003-09-29       Impact factor: 29.690

8.  Tpeak - Tend and Tpeak - Tend /QT ratio as markers of ventricular arrhythmia risk in cardiac resynchronization therapy patients.

Authors:  Chirag Barbhaiya; Jose Ricardo F Po; Sam Hanon; Paul Schweitzer
Journal:  Pacing Clin Electrophysiol       Date:  2012-10-27       Impact factor: 1.976

9.  Mechanical Dyssynchrony by Tissue Doppler Cross-Correlation is Associated with Risk for Complex Ventricular Arrhythmias after Cardiac Resynchronization Therapy.

Authors:  Bhupendar Tayal; John Gorcsan; Antonia Delgado-Montero; Josef J Marek; Kristina H Haugaa; Keiko Ryo; Akiko Goda; Niels Thue Olsen; Samir Saba; Niels Risum; Peter Sogaard
Journal:  J Am Soc Echocardiogr       Date:  2015-09-03       Impact factor: 5.251

10.  Analysis of ventricular activation using surface electrocardiography to predict left ventricular reverse volumetric remodeling during cardiac resynchronization therapy.

Authors:  Michael O Sweeney; Rutger J van Bommel; Martin J Schalij; C Jan Willem Borleffs; Anne S Hellkamp; Jeroen J Bax
Journal:  Circulation       Date:  2010-01-25       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.